ARCHIVES

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Nancy Davidson Elected ASCO President.

March 3, 2006

In Brief: Gallo Signs Agreement With Univ. of Maryland; Donor Gives $5 Million To San Diego Center

May 26, 1995

Upton Tells Press He Wasn’t Hired To Push Prevention

August 5, 1977

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011